Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5AP | P20292 | 1/20 | 0.40 |
| ▸ | FEN1 | P39748 | 1/20 | 0.40 |
| ▸ | CCR1 | P32246 | 5/20 | 0.34 |
| ▸ | CCR8 | P51685 | 5/20 | 0.34 |
| ▸ | CCR5 | P51681 | 3/20 | 0.34 |
| ▸ | ERN1 | O75460 | 1/20 | 0.34 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | GMNN | O75496 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12269099 | 0.96 | ALOX5AP (0.40) | ALOX5APFEN1CCR1CCR8CCR5 | |
| SCHEMBL12268954 | 0.83 | ERN1 (0.38) | ERN1ALDH1A1TP53MMP2BCHE | |
| SCHEMBL13045268 | 0.81 | CYP1A2 (0.41) | KDM4EMAPTALDH1A1HPGDHSD17B10 | |
| SCHEMBL12268893 | 0.81 | PDGFRB (0.48) | PIK3CAMTORBRD4 | |
| SCHEMBL12269075 | 0.80 | POLB (0.54) | ERN1KDM4EMAPTALDH1A1HSD17B10 | |
| SCHEMBL12268913 | 0.78 | ERN1 (0.43) | ERN1ALDH1A1TP53MMP2CYP3A4 | |
| SCHEMBL13045270 | 0.77 | PDGFRB (0.36) | ALOX5APFEN1CCR1CCR8KDM4E | |
| SCHEMBL28716562 | 0.76 | KDM4E (0.42) | CCR1CCR8CCR5KDM4EALDH1A1 | |
| SCHEMBL12269136 | 0.76 | ALDH1A1 (0.37) | CCR1CCR8CCR5KDM4EMAPT | |
| SCHEMBL12269100 | 0.76 | ERN1 (0.36) | ERN1KDM4EALDH1A1CYP3A4HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8021766-B2 | layer containing an organic compound sandwiched between the pair of electrodes; high color purity, high efficiency, high luminance, and a long life; nonaggregate; cost efficiency | CANON KABUSHIKI KAISHA (JP) | 2011-09-20 | — | — | US | disclosed |
| US-8021766-B2 | layer containing an organic compound sandwiched between the pair of electrodes; high color purity, high efficiency, high luminance, and a long life; nonaggregate; cost efficiency | CANON KABUSHIKI KAISHA (JP) | 2011-09-20 | — | — | US | disclosed |
| US-20080286611-A1 | BENZO(GHI)FLUORANTHENE DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2008-11-20 | — | — | US | disclosed |
| US-20080286611-A1 | BENZO(GHI)FLUORANTHENE DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2008-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080286611-A1 | BENZO(GHI)FLUORANTHENE DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | GTF2I, FLI1, GLB1 | ALOX5AP 3827/4885FEN1 1557/4885CCR1 4785/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.